Timothy Bertram - 05 Jul 2023 Form 4 Insider Report for NexImmune, Inc.

Role
Director
Signature
/s/ John Rudy, attorney-in-fact
Issuer symbol
NEXI on OTC
Transactions as of
05 Jul 2023
Net transactions value
$0
Form type
4
Filing time
07 Jul 2023, 16:16:02 UTC
Previous filing
06 Apr 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEXI Stock Option (right to buy) Award $0 +44,983 $0.000000 44,983 05 Jul 2023 Common Stock 44,983 $0.2900 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.